197 related articles for article (PubMed ID: 21430343)
1. Translational research on advanced therapies.
Belardelli F; Rizza P; Moretti F; Carella C; Galli MC; Migliaccio G
Ann Ist Super Sanita; 2011; 47(1):72-8. PubMed ID: 21430343
[TBL] [Abstract][Full Text] [Related]
2. The role of the Istituto Superiore di Sanità as the competent authority for Phase I trials in the translation of advanced therapies.
Popoli P; Cometa MF; Fabi F; Meneguz A
Ann Ist Super Sanita; 2011; 47(1):79-82. PubMed ID: 21430344
[TBL] [Abstract][Full Text] [Related]
3. Regulatory structures for gene therapy medicinal products in the European Union.
Klug B; Celis P; Carr M; Reinhardt J
Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
[TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
5. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
Maekawa T
Rinsho Byori; 2004 May; 52(5):430-4. PubMed ID: 15206130
[TBL] [Abstract][Full Text] [Related]
6. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU.
Brévignon-Dodin L
Biomed Mater Eng; 2010; 20(3):121-6. PubMed ID: 20930319
[TBL] [Abstract][Full Text] [Related]
7. Regulation of advanced therapy medicinal products in Europe and the role of academia.
Pearce KF; Hildebrandt M; Greinix H; Scheding S; Koehl U; Worel N; Apperley J; Edinger M; Hauser A; Mischak-Weissinger E; Dickinson AM; Lowdell MW
Cytotherapy; 2014 Mar; 16(3):289-97. PubMed ID: 24113428
[TBL] [Abstract][Full Text] [Related]
8. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs.
Abou-El-Enein M; Römhild A; Kaiser D; Beier C; Bauer G; Volk HD; Reinke P
Cytotherapy; 2013 Mar; 15(3):362-83. PubMed ID: 23579061
[TBL] [Abstract][Full Text] [Related]
9. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation.
de Wilde S; Veltrop-Duits L; Hoozemans-Strik M; Ras T; Blom-Veenman J; Guchelaar HJ; Zandvliet M; Meij P
Cytotherapy; 2016 Jun; 18(6):797-805. PubMed ID: 27068764
[TBL] [Abstract][Full Text] [Related]
10. European Medicines Agency, CAT Secretariat & US Food and Drug Administration.
Regen Med; 2011 Nov; 6(6 Suppl):90-6. PubMed ID: 21999268
[TBL] [Abstract][Full Text] [Related]
11. Translational medicine policy issues in infectious disease.
Fears R; van der Meer JW; ter Meulen V
Sci Transl Med; 2010 Jan; 2(14):14cm2. PubMed ID: 20371464
[TBL] [Abstract][Full Text] [Related]
12. Role of the blood service in cellular therapy.
Rebulla P; Giordano R
Biologicals; 2012 May; 40(3):218-21. PubMed ID: 22063066
[TBL] [Abstract][Full Text] [Related]
13. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe.
Schuessler-Lenz M; Herberts C; Reischl I; Ruiz S; Celis P; Beuneu C; Kjeken R; Timón M
Adv Exp Med Biol; 2023; 1430():1-21. PubMed ID: 37526839
[TBL] [Abstract][Full Text] [Related]
14. Regulatory aspects for translating gene therapy research into the clinic.
Laurencot CM; Ruppel S
Methods Mol Biol; 2009; 542():397-421. PubMed ID: 19565915
[TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
16. The expanding role of blood and tissue establishments in the development of advanced therapy medicinal products.
Horan A; Warreth S; Hervig T; Waters A
Cytotherapy; 2024 May; 26(5):524-530. PubMed ID: 38441513
[TBL] [Abstract][Full Text] [Related]
17. [A comprehensive assessment of ATMP. Difficulties and approaches].
Thanner M; Nagel E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):843-8. PubMed ID: 21698538
[TBL] [Abstract][Full Text] [Related]
18. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
Bakopoulou A
J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
[TBL] [Abstract][Full Text] [Related]
19. Current regulatory issues in cell and tissue therapy.
Burger SR
Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
[TBL] [Abstract][Full Text] [Related]
20. European regulatory tools for advanced therapy medicinal products.
Flory E; Reinhardt J
Transfus Med Hemother; 2013 Dec; 40(6):409-12. PubMed ID: 24474890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]